For Immediate Release:
21 January 2021
Dipti M Kapoor; [email protected]
Hiraj Laljani; [email protected]
Commission Incorporates Recommendations Made by PETA India
New Delhi – The Indian Pharmacopoeia Commission (IPC) – which is responsible for setting standards for drugs – incorporating recommendations from People for the Ethical Treatment of Animals (PETA) India, proposed a significant reduction in required tests on animals for producing recombinant antibody drugs and for developing test methods for assessing drugs action or effects in living systems. The IPC has invited comments from stakeholders on the proposed drafts before 22 February 2021.
PETA India pointed out in its recommendation that available non-animal methods and practices can effectively replace the use of cows, rabbits, rats, and other animals for the production of drugs and for the development of test methods for assessing drugs. The IPC’s proposal also mandates that companies must justify their continued use of animals for these applications and that the number of animals used must be minimised to the greatest extent possible.
“PETA India applauds the IPC for proposing to reduce the use of animals in drug production and for recommending the inclusion of modern, non-animal test methods,” says PETA India Science Policy Adviser Dr Dipti Kapoor. “PETA India is calling on the companies producing recombinant antibodies and developing bioassays to show their support for the IPC’s progressive initiatives.”
PETA India – whose motto reads, in part, that “animals are not ours to experiment on” and which opposes speciesism, a human-supremacist worldview – notes that the vast physiological differences between humans and other species mean that the results of animal tests are often misleading.
As a member of the IPC’s subcommittee on alternatives to animal experiments, PETA India is invited to attend workgroup meetings and will continue to suggest changes to replace the use of animals with non-animal tests, which will protect animals and improve the quality and reproducibility of research.